Integra LifeSciences received 510(k) clearance from the FDA for the Vu aPOD prime anterior lumbar interbody fusion device, according to a company news release.
The Vu aPOD allows physicians to utilize two fixation options: securing it with two self-tapping bone screws (which does not require additional supplemental fixation) or securing it with the SpinPlate internal buttress plate technology (which requires supplemental fixation). The device's anatomic design and large graft window help to facilitate fusion.
Read the Integra LifeSciences release on the Vu aPOD.
Read other coverage on Integra LifeSciences:
- Integra LifeSciences Launches New Surgical Spine Instruments
- Integra LifeSciences Opens Spine Research, Education and Training Center in Irvine, California
- Integra LifeSciences Reports 8% Increase in Total Revenue
The Vu aPOD allows physicians to utilize two fixation options: securing it with two self-tapping bone screws (which does not require additional supplemental fixation) or securing it with the SpinPlate internal buttress plate technology (which requires supplemental fixation). The device's anatomic design and large graft window help to facilitate fusion.
Read the Integra LifeSciences release on the Vu aPOD.
Read other coverage on Integra LifeSciences:
- Integra LifeSciences Launches New Surgical Spine Instruments
- Integra LifeSciences Opens Spine Research, Education and Training Center in Irvine, California
- Integra LifeSciences Reports 8% Increase in Total Revenue